Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 1, 2001, Pages 33-39

  Tschampa, H J ^a,b   Neumann, M ^b   Zerr, I ^a   Henkel, K ^a   Schroter A ^a   Schulz Schaeffer, W J ^b   Steinhoff, B J ^c   Kretzschmar, H A ^b   Poser, S ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Epilepsiezentrum ^*  (Germany)

^c Epilepsie Zentrum   (Germany)

Author keywords

Alzheimer's disease; Creutzfeldt Jakob disease; Dementia with Lewy bodies; Diagnosis

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MUSCLE RIGIDITY; MYOCLONUS; NEUROPATHOLOGY; PARKINSONISM; PRIORITY JOURNAL;

EID: 0034956544     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.1.33     Document Type: Article

References (38)

1. Poser S, Zerr I, Schulz-Schaeffer W, et al. Die Creutzfeldt-Jakob-Krankheit. Eine Sphinx der heutigen Neurobiologie. Dtsch Med Wochenschr 1997;122:1099-105.
2. Gómez-Tortosa E, Ingraham AO, Irizarry MC, et al. Dementia with Lewy bodies. J Am Geriatr Soc 1998;46: 1449-58.
3. Häfner H. Epidemiology of Alzheimer's disease. In: Maurer K, et al, eds. Epidemiology, neuropathology, neurochemistry and clinics. Wien: Springer, 1990:23-39.
4. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force of Alzheimer's disease. Neurology 1984;34:939-944.
5. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
6. Heyman A, Fillenbaum GG, Gearing M, et al. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease. Neurology 1999;52:1839-44.
7. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of the clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-7.
8. Litvan MD, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnosis of Lewy body disease, Parkinson disease and dementia with Lewy bodies. Arch Neurol 1998;55:969-78.
9. Louis ED, Klatka LA, Liu Y, et al. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997;48:376-80.
10. Faden AI, Townsend J. Myoclonus in Alzheimer disease. A confusing sign. Arch Neurol 1976;33:278-80.
11. Katz PR, Chutkow JG. Dementia, myoclonus and EEG findings typical of Creutzfeldt-Jakob disease in a patient with Alzheimer's disease. N Y S J Med 1986;86:157-8.
12. Watson CP. Clinical similarity of Alzheimer and Creutzfeldt-Jakob disease. Ann Neurol 1979;6:368-9.
13. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, et al. Diffuse Lewy body disease and progressive dementia. Neurology 1988;38:1520-8.
14. Windl O, Giese A, Schulz-Schaeffer W, et al. Molecular genetics of human prion diseases in Germany. Hum Genet 1999;105:244-52.
15. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-88.
16. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.
17. Otto A, Zerr I, Lantsch M, et al. Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1998;64:524-8.
18. McKeith IG, Fairbairn AF, Perry RH, et al. Neuroleptic hypersensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-8.
19. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53:162-6.
20. World Health Organization. Human transmissible spongiform encephalopathies. Weekly Epidemiological Record 1998; 73:361-5.
21. Brown P, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-90.
22. Hyman BT, Trojanowski JQ. Editorial recommendations for the postmortem diagnosis of Alzheimer's disease from the National Institute on Aging and the Reagan Institute Working Group on the diagnostic criteria for the neuropathological assessment of Alzheimer's disease. J Neuropathol Exp Neurol 1997;56:1095-7.
23. Kretzschmar HA, Ironside JW, DeArmond SJ, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913-20.
24. Mirra SS, Heyman AA, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
25. Braak H, Braak E. Neuropathologic staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
26. Brown P, Gibbs CJJr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29.
27. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: clinical features. J Neurol Neurosurg Psychiatry 1984;47: 134-40.
28. Poser S, Mollenhauer B, Krauß A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122:2345-51.
29. Lopez OL, Litvan I, Catt KE, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999;53:1292-9.
30. Hauser WA, Morris ML, Heston LL, et al. Seizures and myoclonus in Alzheimer's disease. Neurology 1986;36: 1226-30.
31. Pantel J, Schröder J. Posterior cortical atrophy: ein neues Demenzsyndrom oder Sonderform des Morbus Alzheimer? Fortschr Neurol Psychiatr 2000;64:492-508.
32. Yamamoto T, Imai T. A case of diffuse Lewy body disease and Alzheimer's disease with periodic synchronous discharges. J Neuropathol Exp Neurol 1988;47:536-48.
33. Crystal HA, Dickson DW, Lizardi JE, et al. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40: 1523-8.
34. Aksamit AJ, Homburger HA, Preissner CM. Creutzfeldt-Jakob disease: correlation with spinal fluid NSE and 14-3-3 proteins. J Neurol 1999;246(suppl 1):I-33
35. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46: 224-33.
36. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. A clinical diagnosis in Creutzfeldt-Jakob disease: identification of unkommon variants? Ann Neurol 2000;48:323-9.
37. Samman I, Schulz-Schaeffer WJ, Wohrle JC, et al. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. J Neurol Neurosurg Psychiatry 1999;67:678-81.
38. Schroter A, Zerr I, Henkel K, et al. Magnetic resonance imaging (MRI) in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-7.